EGFR/C797S-IN-1 是一种有效的EGFR-C797S抑制剂,IC50值为 0.128 μM。EGFR/C797S-IN-1 显示出抗增殖活性和抗肿瘤活性。EGFR/C797S-IN-1 以剂量依赖的方式抑制 P-EGFR 蛋白的表达。
生物活性 | EGFR/C797S-IN-1 is a potentEGFR-C797Sinhibitor with anIC50value of 0.128 μM. EGFR/C797S-IN-1 shows anti-proliferative activity and anti-tumor activity. EGFR/C797S-IN-1 inhibits the expression of p-EGFR in a dose-dependent manner[1]. |
IC50& Target[1] | EGFRL858R/T790M/C797S 0.128 μM (IC50) |
|
体外研究 (In Vitro) | EGFR/C797S-IN-1 (compound 14d) (0-10 μM; 72 h) 显示抗增殖活性,对BaF3-EGFRL858R/T790M/C797S, BaF3-EGFR19del/T790M/C797S的 IC50值分别为 0.75、0.09 μM[1]。 EGFR/C797S-IN-1 (1-10000 nM; 24 h) 以剂量依赖性降低 p-EGFR、p-AKT、p-ERK 蛋白的表达[1]。
Cell Proliferation Assay[1] Cell Line: | BaF3 cells with EGFRL858R/T790M/C797S and EGFR19del/T790M/C797S Mutations | Concentration: | 0-10 μM | Incubation Time: | 72 h | Result: | Showed anti-proliferative activitie with IC50s of 0.75, 0.09 μM for BaF3-EGFRL858R/T790M/C797S, BaF3-EGFR19del/T790M/C797S, respectively. |
Western Blot Analysis[1] Cell Line: | BaF3-EGFRL858R/T790M/C797S, BaF3-EGFR19del/T790M/C797S cells | Concentration: | 1, 10, 100, 1000, 10000 nM | Incubation Time: | 24 h | Result: | Decreased the expression of p-EGFR, p-AKT. p-ERK protein in a dose dependent manner. |
|
体内研究 (In Vivo) | EGFR/C797S-IN-1 (10、30 mg/kg;每日一次,持续 14 天) 呈剂量依赖性显著降低小鼠体内的肿瘤生长[1]。
Animal Model: | SD male rats[1] | Dosage: | 1 mg/kg for i.v.; 10 mg/kg for p.o. | Administration: | i.v. or p.o. | Result: | Displayed good biochemical activity and promising cellular activity. |
Animal Model: | BALB/c nude mice (BaF3-EGFR19del/T790M/C797S xenograft model)[1] | Dosage: | 10, 30 mg/kg | Administration: | I.p.; daily for 14 days | Result: | Displayed an obvious suppressive effect of tumor growth, with the TGI at 51.36% and 67.95% at the dosage of 10 mg/kg and 30 mg/kg, respectively. |
|
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |